Cargando…

Pathogenic Feed-Forward Mechanisms in Alzheimer’s and Parkinson’s Disease Converge on GSK-3

Alzheimer’s disease (AD) and Parkinson’s disease (PD) share many commonalities ranging from signaling deficits such as altered cholinergic activity, neurotrophin and insulin signaling to cell stress cascades that result in proteinopathy, mitochondrial dysfunction and neuronal cell death. These patho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Albeely, Abdalla M., Ryan, Scott D., Perreault, Melissa L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6311352/ https://www.ncbi.nlm.nih.gov/pubmed/30598867 http://dx.doi.org/10.3233/BPL-180078

Ejemplares similares

Cortical dopamine D5 receptors regulate neuronal circuit oscillatory activity and memory in rats
por: Albeely, Abdalla M., et al.
Publicado: (2023)

A Simple, Lightweight, and Low-Cost Customizable Multielectrode Array for Local Field Potential Recordings
por: Quansah Amissah, Richard, et al.
Publicado: (2023)

The GSK3 hypothesis of Alzheimer's disease
por: Hooper, Claudie, et al.
Publicado: (2008)

GSK3 and Alzheimer’s Disease: Facts and Fiction…
por: Kremer, Anna, et al.
Publicado: (2011)

GSK-3 and lysosomes meet in Alzheimer’s disease
por: Avrahami, Limor, et al.
Publicado: (2013)

The potential convergence of NLRP3 inflammasome, potassium, and dopamine mechanisms in Parkinson’s disease
por: Pike, Adrianne F., et al.
Publicado: (2022)

Disparate Effects of Lithium and a GSK-3 Inhibitor on Neuronal Oscillatory Activity in Prefrontal Cortex and Hippocampus
por: Nguyen, Tuan, et al.
Publicado: (2018)

Convergent pathways in Parkinson’s disease
por: Cherubini, Marta, et al.
Publicado: (2017)

GSK3 and p53 - is there a link in Alzheimer's disease?
por: Proctor, Carole J, et al.
Publicado: (2010)

GSK-3β, a pivotal kinase in Alzheimer disease
por: Llorens-Marítin, María, et al.
Publicado: (2014)

GSK3β and Tau Protein in Alzheimer’s Disease and Epilepsy
por: Toral-Rios, Danira, et al.
Publicado: (2020)

GSK-3 and Tau: A Key Duet in Alzheimer’s Disease
por: Sayas, Carmen Laura, et al.
Publicado: (2021)

Glycogen Synthase Kinase-3: A Focal Point for Advancing Pathogenic Inflammation in Depression
por: McCallum, Ryan T., et al.
Publicado: (2021)

GSK-3 in Neurodegenerative Diseases
por: Lei, Peng, et al.
Publicado: (2011)

Feed-Forward in the LHC
por: Pereira, M, et al.
Publicado: (2012)

Inflammatory signaling sensitizes Piezo1 mechanotransduction in articular chondrocytes as a pathogenic feed-forward mechanism in osteoarthritis
por: Lee, Whasil, et al.
Publicado: (2021)

The therapeutic potential of mesenchymal stem cells in Alzheimer's disease: converging mechanisms
por: Turgeman, Gadi
Publicado: (2015)

Convergence Rates of Forward–Douglas–Rachford Splitting Method
por: Molinari, Cesare, et al.
Publicado: (2019)

Crosstalk between Cdk5 and GSK3β: Implications for Alzheimer's Disease
por: Engmann, Olivia, et al.
Publicado: (2009)

Role of GSK-3β Inhibitors: New Promises and Opportunities for Alzheimer’s Disease
por: Shri, Suggala Ramya, et al.
Publicado: (2023)

Convergent genomic and pharmacological evidence of PI3K/GSK3 signaling alterations in neurons from schizophrenia patients
por: Stertz, Laura, et al.
Publicado: (2020)

The convergent and divergent patterns in brain perfusion between Alzheimer's disease and Parkinson's disease with dementia: An ASL MRI study
por: Chen, Hongri, et al.
Publicado: (2022)

The power of the feed-forward sweep
por: VanRullen, Rufin
Publicado: (2008)

Truncation and activation of GSK-3β by calpain I: a molecular mechanism links to tau hyperphosphorylation in Alzheimer's disease
por: Jin, Nana, et al.
Publicado: (2015)

Speed of convergence in global value chains: Forward or backward linkage
por: Wuri, Josephine, et al.
Publicado: (2023)

Dietary regulation of PI3K/AKT/GSK-3β pathway in Alzheimer’s disease
por: Kitagishi, Yasuko, et al.
Publicado: (2014)

Small-Molecule Inhibitors of GSK-3: Structural Insights and Their Application to Alzheimer's Disease Models
por: Kramer, Thomas, et al.
Publicado: (2012)

Feed-Forward Neural Network Prediction of the Mechanical Properties of Sandcrete Materials
por: Asteris, Panagiotis G., et al.
Publicado: (2017)

Diagnosis of Alzheimer's Disease Using Dual-Tree Complex Wavelet Transform, PCA, and Feed-Forward Neural Network
por: Jha, Debesh, et al.
Publicado: (2017)

The Convergence of Dopamine and α-Synuclein: Implications for Parkinson’s Disease
por: Mor, Danielle E, et al.
Publicado: (2018)

Tune Feed-Forward for PEP-II
por: Decker, Franz Josef, et al.
Publicado: (2001)

Propagating synchrony in feed-forward networks
por: Jahnke, Sven, et al.
Publicado: (2013)

Shared Mechanisms of Neurodegeneration in Alzheimer's Disease and Parkinson's Disease
por: Xie, Anmu, et al.
Publicado: (2014)

Mechanisms and Therapeutic Implications of GSK-3 in Treating Neurodegeneration
por: Rippin, Ido, et al.
Publicado: (2021)

Disease modification in Parkinsonism: obstacles and ways forward
por: Höllerhage, M., et al.
Publicado: (2022)

Application of feed forward and recurrent neural networks in simulation of left ventricular mechanics
por: Dabiri, Yaghoub, et al.
Publicado: (2020)

Novel Reporter Alleles of GSK-3α and GSK-3β
por: Barrell, William B., et al.
Publicado: (2012)

MAPT rs242562 and GSK3B rs334558 are associated with Parkinson’s Disease in central China
por: Yu, Lan, et al.
Publicado: (2014)

Genetic insights into immune mechanisms of Alzheimer’s and Parkinson’s disease
por: Nott, Alexi, et al.
Publicado: (2023)

Divergent and Convergent Evolution of Fungal Pathogenicity
por: Shang, Yanfang, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_73aku3v9n2frl4m5suhuer70ou